Home/AKIGAI/Marte Cameron
MC

Marte Cameron

MD PhD, Co-Founder, Clinical Oncologist, Researcher, Inventor

AKIGAI

Therapeutic Areas

AKIGAI Pipeline

DrugIndicationPhase
EGFR Inhibitor (Tyrosine Kinase Inhibitor - oral)Chronic Neuropathic PainPreclinical
EGFR Inhibitor (Monoclonal Antibody - parenteral)Chronic Neuropathic PainPreclinical
Modified/Targeted EGFR InhibitorChronic Neuropathic PainDiscovery